CITIGROUP INC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 48 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$492,575
+83.8%
279,000
+75.5%
0.00%
Q2 2023$268,049
-8.7%
159,000
+4.6%
0.00%
Q1 2023$293,650
-70.6%
152,000
-71.6%
0.00%
-100.0%
Q4 2022$999,380
+19.4%
535,000
+6.6%
0.00%0.0%
Q3 2022$837,000
+8.4%
502,000
-18.5%
0.00%0.0%
Q2 2022$772,000
+517.6%
616,000
+548.4%
0.00%
Q1 2022$125,000
-82.4%
95,000
-82.4%
0.00%
Q2 2021$712,000
+1680.0%
540,000
+1641.9%
0.00%
Q1 2021$40,000
+60.0%
31,000
+210.0%
0.00%
Q4 2020$25,000
-95.3%
10,000
-95.8%
0.00%
Q2 2019$532,000
-90.5%
239,000
-92.3%
0.00%
-100.0%
Q1 2019$5,592,0003,099,0000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$148,264,0002.95%
DeepCurrents Investment Group LLC 45,997,000$76,672,0002.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$64,158,0001.47%
WOLVERINE ASSET MANAGEMENT LLC 71,012,000$118,356,0001.28%
Opti Capital Management, LP 3,000,000$5,013,0000.46%
MIZUHO SECURITIES USA LLC 1,663,000$2,766,0000.38%
Verition Fund Management LLC 25,954,000$21,680,6590.24%
Aequim Alternative Investments LP 5,000,000$8,345,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 3,831,000$6,522,0000.18%
LORD, ABBETT & CO. LLC 23,424,000$39,095,0000.14%
View complete list of SAREPTA THERAPEUTICS INC shareholders